1.
Open Forum Infect Dis
; 7(1): ofz535, 2020 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31915716
RESUMO
The frequency of clinically relevant transmitted drug resistance mutations (DRMs) against drugs used for 2-drug regimens was 15.6%, but only 2% were not eligible for 1 or more 2-drug regimens. More than 50% of patients harboring any clinically relevant DRMs were found to be part of genetic transmission clusters.